Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Phase I, Single-dose Study with SB206 in Healthy Japanese Adults
jRCT2031220073Phase 1Completed
- Sponsor
- Sato Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of berdazimer in molluscum contagiosum (MC) (2 arms), sponsored by Sato Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
berdazimer
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on jRCT2031220073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220073.